==== Front J Pers Med J Pers Med jpm Journal of Personalized Medicine 2075-4426 MDPI 33256123 10.3390/jpm10040249 jpm-10-00249 Review Visualization and Measurements of Blood Cells Flowing in Microfluidic Systems and Blood Rheology: A Personalized Medicine Perspective https://orcid.org/0000-0002-3884-6496Pinho Diana 12*† https://orcid.org/0000-0002-9447-4746Carvalho Violeta 3 https://orcid.org/0000-0001-7986-8934Gonçalves Inês M. 4 https://orcid.org/0000-0002-7464-3944Teixeira Senhorinha 5 https://orcid.org/0000-0003-3428-637XLima Rui 36 1 Center for MicroElectromechanical Systems (CMEMS-UMinho), Campus de Azurém, University of Minho, 4800-058 Guimarães, Portugal 2 Research Centre in Digitalization and Intelligent Robotics (CeDRI), Campus de Santa Apolónia, Instituto Politécnico de Bragança, 5300-253 Bragança, Portugal 3 MEtRICs, Mechanical Engineering Department, Campus de Azurém, University of Minho, 4800-058 Guimarães, Portugal; violeta.carvalho@dem.uminho.pt (V.C.); rl@dem.uminho.pt (R.L.) 4 Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal; id9385@alunos.uminho.pt 5 ALGORITMI Center (CAlg), University of Minho, 4800-058 Guimarães, Portugal; st@dps.uminho.pt 6 CEFT, Faculdade de Engenharia da Universidade do Porto (FEUP), Rua Dr. Roberto Frias, 4200-465 Porto, Portugal * Correspondence: diana.pinho@inl.int or diana@ipb.pt† Current address: INL—International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, Portugal. 26 11 2020 12 2020 10 4 24922 9 2020 23 11 2020 © 2020 by the authors.2020Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Hemorheological alterations in the majority of metabolic diseases are always connected with blood rheology disturbances, such as the increase of blood and plasma viscosity, cell aggregation enhancement, and reduction of the red blood cells (RBCs) deformability. Thus, the visualizations and measurements of blood cells deformability flowing in microfluidic devices (point-of-care devices) can provide vital information to diagnose early symptoms of blood diseases and consequently to be used as a fast clinical tool for early detection of biomarkers. For instance, RBCs rigidity has been correlated with myocardial infarction, diabetes mellitus, hypertension, among other blood diseases. In order to better understand the blood cells behavior in microfluidic devices, rheological properties analysis is gaining interest by the biomedical committee, since it is strongly dependent on the interactions and mechanical cells proprieties. In addition, the development of blood analogue fluids capable of reproducing the rheological properties of blood and mimic the RBCs behavior at in vitro conditions is crucial for the design, performance and optimization of the microfluidic devices frequently used for personalized medicine. By combining the unique features of the hemorheology and microfluidic technology for single-cell analysis, valuable advances in personalized medicine for new treatments and diagnosis approach can be achieved. hemorheologyblood diseasesmicrofluidicssingle-cell analysisred blood cells deformabilityblood analogues ==== Body 1. Introduction Blood viscosity and red blood cells (RBCs) deformability are the main contributors to the maintenance and regulation of microcirculation. Many studies have demonstrated that modifications in the hemorheological properties were closely related to several metabolic diseases. Hemorheology, the study of deformation and blood flow, have been more focused on RBC rheology, relating the deformation and aggregation of RBCs, since erythrocytes comprise the major components in blood. However, RBCs studies alone may not show the progress of the disease, thus complementary studies are needed, such as whole blood and plasma viscosity, RBC aggregation, deformability measurements, blood cells population count, and morphological analysis [1,2,3,4,5,6,7] must be integrated as to further develop an efficient point-of-care tool. Blood and plasma viscosity are risk factors essentially, for example for atherosclerosis [1,8,9] and other studies exposed that RBCs rheological changes have been observed in patients with hypertension [1,8,10] and diabetes mellitus [11,12,13,14], which are diseases more often associated with obesity [8,15]. Obesity-related blood rheological disturbances are currently being investigated as one of the risk factors for several co-morbid pathologies because they play a significant role in microcirculation blood flow [8]. Lee et al., 2019 [6] have performed a review with the most recent clinical studies of diabetic kidney disease associated with hemorheological parameters, demonstrating that critical shear-rate and –stress, measured by a microfluidic aggregometry [6], aggregation index and RBC deformability elongation index, measured by a microfluidic ektacytometry [16], must be combined as a tool for a successful diagnosis of disease stage and possible derivate complications. Additionally, Caprari et al., (2019) [7] have demonstrated that blood viscosity and RBC aggregation increase with the decreasing of the RBCs deformability, by using blood samples from subjects with sickle cell anemia. However, no microfluidic technologies have been used in these studies. Likewise, the electrical blood behavior can be used to help in the isolation of plasma and populations of blood cells and to quantify hemorheological properties [17,18]. Note that the electrical properties of blood tend to change due to hemorheological variations of the RBCs behavior and blood plasma. Several impedance measurements can be related to RBCs behavior, for example, the electrical impedance of blood flow increases at low shear rates because of RBC aggregation. A clear example that the electrical behavior of blood can help in the clinical diagnosis is the work developed by Yeom et al., (2015) [17]. In this work, a simple speckle analysis based on a microfluidic measurement method to detect the hyperaggregation caused by diabetes was used. By this method they have demonstrated the potential of evaluating the differences of the biophysical properties of cardiovascular diseases’ blood samples [19]. However, the measurements were restricted on superficial vessels, and ultrasonic signal requires calibration as a function of the flow speed under steady flow conditions. Therefore, the progress on hemorheology, regarding the phenomena associated with blood components, their interactions and impact on blood properties, and blood flow, i.e., the hemorheological profile of the patients, strongly dependent on the interactions and mechanical properties of blood cells and in particular with the behavior of the RBCs, can bring further insight into the human health state and it can be an important parameter in clinical diagnosis (Figure 1). Implementation of rapid test technologies in clinical environments leads to minimal user intervention during operation; user-friendly, easy-to-use, and simple detection platforms; high diagnostic sensitivity and specificity; immediate clinical assessment; and low manufacturing and consumables costs. However, it should be noted that it essential to achieve high specificity in the detection and read of biomarkers. Microfluidics has potential to provide all that solutions since it enables the processing of samples that are not available in large quantities (e.g., cells from patient biopsies), reduce cost, provides a high level of automation, and allows the set-up of complex models (for example for cancer studies). Another advantage more closely related to the rapid tests is the possibility of using small amounts of different kind’s body fluids such as blood, urine, saliva, and sweat. Separation and sorting of different populations or subpopulations of blood cells from unprocessed or minimally processed blood specimens is of interest to both clinical and biomedical applications and holds a central role in diagnosis and prognosis of physiologic and pathologic conditions. In particular, plasma separation or cells separation from plasma has been achieved through several mechanisms, including acoustophoresis [20,21], dielectrophoresis [20,22], electrohydrodynamics [20,23], and physical hydrodynamic manipulation [20,24]. Several works have demonstrated that, by using hydrodynamic [25], hemodynamic [26,27,28], and physical filtration [25,29], high isolation efficiency is achieved. By physical filtration, more than 95% of the RBCs and 27% of the white blood cells (WBCs) are removed from whole blood [30], and this method is the most used to isolate and separated RBCs and WBCs from plasma. For the hydrodynamic manipulation several authors developed microfluidic devices that takes advantage of the intrinsic features of blood flow in the microcirculation, such as plasma skimming and leukocyte margination, to separate WBCs directly from whole blood. For example, Fujiwara et al., (2009) [31] and other authors have found evidence that it is possible to create an artificial cell-free layer (CFL) under appropriate hemodynamic and geometrical conditions, and also that CFL thickness is strongly influenced by the RBC deformability, which can be useful to separate plasma from the blood cells, as Pinho et al., (2013) [26] have also demonstrated. However, pre- and post-sample preparation are still needed, and hemorheological properties most of the times are not quantified. One of the long term, goals in the field of microfluidics is to create integrated, portable clinical diagnostic devices for home and bedside use, eliminating time-consuming laboratory analysis procedures. Thus, it is imperative the development of integrated microfluidic devices, as described and implemented by Peng et al., 2019 [32], that combine several well-known methodologies from blood sample processing to cells population separation/sorting to single-cell hemorheological analysis, in order to achieve a powerful tool able to perform successful and accurate results. This opportunity to develop such complete tool will address new point-of-care systems and it can be a powerful not only for blood flow studies but also, for liquid biopsy handling and analysis. 2. Microfluidics Tools: Single-Cell Approach Owing to recent developments in microfluidic technology, several hemorheological point-of-care devices have been designed that allow the possibility of conducting extensive clinical studies using hemorheological measurements [6,33]. The field of microfluidics technology is characterized by the study and manipulation of fluids in microstructures at the submillimeter length scale and it has emerged as an important tool to be applied in many engineering and biomedical fields [34]. The dimensions of such technology, normally less than 1 mm, conduct to useful methodologies with significant advantages, such as the volume of fluids within these channels (µl or even pL of sample) as well as, the reduction of the amount of necessary expensive reagents and analytes, sample loss, and dilution, but keeping their efficiency and high sensibility. The high-throughput for larger samples manipulation and analysis combined with parallel and multiple functionalities will avoid contaminations and handling errors. Additional advantages appear with the development of fabrication techniques used to design the microfluidic systems at the micro and nano dimensions. These techniques are relatively diversified and include inexpensive strategies, in particular with the progress of the 3D printing technology [35,36]. The cost reduction and the performance enhancement were appellatives for the biomedical research community to create novel strategies for applications in the diagnostics and/or therapy of several diseases, providing new sets of solutions to overcome the shortcomings of conventional detection and treatment methods available in clinics and hospitals [37]. The first routine in clinical practice is the complete blood cells count, determining the frequency of all major blood cells, along with blood biochemistry and molecular markers detection. Thus, microfluidic technologies can be used to obtain a variety of interesting applications, such as PCR amplification and electrophoresis [38,39], immunoassays and flow cytometry [40,41], proteins for analysis via mass spectrometry [42], DNA analysis [43], chemical gradient formation [44], cell manipulation and separation [27,45,46], cell patterning [47] and single-cell analysis [25,48,49,50,51,52], NMR [53,54,55], electrochemical [56,57] and measurements such as fluid viscosity [58,59], and pH [60,61] of the blood samples and its constituents. Separation of cells/molecules or other fluid elements plays also an important role in sample preparation for biological, biochemical, and pharmaceutical applications [24]. Additionally, cell sorting and separation need to be carried out precisely to develop microfluidic systems as an accurate tool with high detection and quantification efficiency, leading to an efficient single-cell analysis [62]. Different kinds of single-cell analysis can be performed depending on what we are observing, e.g., single-cell immunology, single-cell biology, single-cell systems biology, single-cell pharmacology, and single-cell toxicology. For instance, single-cell studies require cells capture/isolation using different microfluidic methods, such as hydrodynamic, electrical, optical, magnetic, and acoustic methods [62], and various detection methods, such as fluorescence microscopy, fluorometry and mass spectroscopy, optical or electrochemical [62] that can be combined with passive [27,28,63], active [29,64,65] or/and hybrid isolation methods [66]. As for either single-cell manipulation or single-cell analysis, it is hard to obtain a comprehensive result by merely using one method [62]. Therefore, two or more methods are usually combined into a microfluidic system comprising several single-cell testing modules [22,67]. RBCs’ deformability (the ability to change their shape and pass through small capillaries and splenic sinuses), a single-cell measurement, has been considered a potential biomarker for blood disorders, such as diabetes [68], obesity [69], and malaria [70,71,72]. Depending on the diseases, several alterations can occur in the viscoelasticity of the membrane of the cell or in the cytoplasmic viscosity, or even both. For example, nonenzymatic glycation of several proteins, especially red cell-membrane glycoproteins and hemoglobin, has been found in patients with diabetes, and such a biochemical modification of the erythrocyte is one factor that may account for altered rheological properties of human erythrocytes in diabetes [19]. Reduction in cancer-cell elasticity and stiffness-sensing ability could cause the loss of cancer cells to response to microenvironmental changes and it was suggested as important biomarkers of a cancer-cell phenotype, mechanosensation, or mechanotransduction [17]. Other diseases that include changes in RBCs stiffness due to cytoskeletal modifications such as spherocytosis, increased cell deformability of invasive cancer cells compared to benign or normal cells of the same origin, and changes in stiffness of leukocytes in response to activation with antigens or other signals. An increased deformability has also been identified as a potential biomarker for pluripotent stem cells. Primarily, the available methods to measure the biomechanical properties of RBCs, such as the conventional rotational viscometer, ektacytometer, and micro-pore filtration assay, use high sample concentrations, since they have been used to measure the blood viscosity and other rheological properties, but they are generally expensive, labor-intensive, and do not provide a direct and detailed source of information on the mechanical properties of the RBCs. As single-cell techniques, micropipette aspiration, and optical tweezers, are also extremely popular for measuring the mechanical properties of the RBC membrane. However, these techniques also have several drawbacks, such as a low-throughput, labor-intensive, and static process. Additionally, it is argued that these methods do not represent the actual RBC deformability that happens during microcirculation [5,50]. For this reason, the deformability of RBCs, by using microfluidic devices to measure the deformation of blood cells, has gained great attention. RBCs Deformability in Microfluidic Devices As previously mentioned, malaria and diabetes are some of the several existent RBCs-related diseases that can promote significant alterations in the RBC deformability. For this reason, the deformability of RBCs has been extensively studied and, recently, microfluidic devices have become the preferred method to measure the deformation of blood cells due to their dimensional match with biological cells and the aforementioned advantages. A summary of the main features of several cell deformability studies performed in microfluidic devices is presented in Table 1. Lima’s and Lee’s research group have applied a hyperbolic shaped microchannel [50,51,73,74] to study the RBCs deformability demonstrating that single RBCs deformability analysis can provide more precise and detailed information about blood disorders. In a more recent study performed by Faustino et al., 2018 [23], based in the work of Pinho et al., 2013 [26] and Rodrigues et al., 2015 [27], they have combined several passive sorting methods. In this work, separation by the biomechanical cells properties, hydrodynamic phenomena and hemodynamic cells behavior were fully integrated in a single microfluidic system to achieve single RBC visualizations and respective mechanical properties of cells (i.e., deformability) analysis. In addition, the separation efficiency was quantified by a spectrophotometric method. Briefly, this integrated microfluidic platform comprises several stages of cross-flow filtration barriers with different gaps and nine different outlets in order to access partial separation of RBCs and consequentially their deformability. At each outlet, a sequence of hyperbolic channels for cells visualization and deformability assessments is presented, which simultaneously can assess RBCs, WBCs, and other kinds of cells. The cells’ deformability was obtained, due to the use of hyperbolic-shaped contractions, which generate constant strain-rates that makes this tool a promising strategy for measuring RBCs deformability under a well-controlled microenvironment. More detailed information about this device can be found at the work performed by Faustino et al., 2018 [23]. Another example, showing the potential of this microfluidic approach, was the work performed by Rodrigues et al., 2016 [73]. In this study, this methodology was used to evaluate the impact of nanoparticles on human RBCs. The applied microfluidic tool has shown that a small amount of nanoparticles can affect the RBC deformability, where other hemocompatibility tests (such as the hemolysis analysis) did not show any influence. Hence, this study has shown that this microfluidic tool has a higher sensitivity to detect small changes of RBC deformability, task not possible by using conventional hemocompatibility methods. This microfluidic tool is currently being applied in novel studies including pathological flow studies and hemocompatibility tests (Figure 2). In addition to the previous investigations, an innovative micro-device to study the cell deformability has been developed by Rubio et al., 2019 [75]. In this study, the authors developed fire shaped axisymmetric borosilicate micro nozzles whose production is fast, simple, and use low-cost equipment, comparing with other similar microfluidic devices found in the literature. Moreover, the shape of the converging area of the micro nozzles allowed to obtain an extensional flow, which is proper to produce a controlled deformation or elongation of microparticles/cells to measure the deformation index (DI). Although this is a preliminary study, the use of these types of micro nozzles have great potential to detect small changes of blood cell mechanical properties and it may become an interesting platform to investigate new treatments associated with pathological alterations of blood cell properties. Despite the variety of experimental microfluidic studies performed to evaluate the RBCs’ deformability, some considerations must be taken into account during the flow measurements. For instance, in a study conducted in a hyperbolic converging microchannel, the effect of orientation of cells on the velocity and deformation was analyzed. As can be observed in Figure 3a, the velocity is almost the same for all RBCs, however, the deformation of the cell is dependent on its orientation and shape (Figure 3b). Depending on the orientation and shape, blood cells will have different deformability indexes. Therefore, attention must be taken in choosing the cell to assess the deformability. In this way, automatic methods may not be the most appropriate approach to measure individual blood cells, as they do not have this sensibility yet and, therefore, the results may not be as reliable as the manual methods. Most of the works have been developed around the analysis of blood-based biomarkers. However, precise information about malignancies can also be found through liquid biopsies [76] by isolating and analyzing rare cells, classical protein biomarkers, exosomes, circulating-free nucleic acids, tumor-derived vesicles or proteins, and metabolites [77]. Despite all this physical and hydrodynamic methods, due to the simplicity of electrical measurement, measuring RBC deformability electrically was also attempted in microfluidic systems. Zeng et al., 2013 [78] measured electrically the deformability of RBCs with a two-stage microdevice. A low-frequency voltage signal was established across the microfluidic channel, and electrical current signal was sampled continuously when RBCs passed through a small microchannel [78]. jpm-10-00249-t001_Table 1Table 1 Main features of several cell deformability studies performed in microfluidic devices. Microfluidic Device Cell Types Main Flow Phenomenon Approach to Measure the Degree of Deformability Configuration Main Key Observations References Hyperbolic converging microchannels Human RBCs (healthy and diseased) Extensional flow Deformation Ratio (DR)=LD The proposed device is able to detect changes in DR of the RBCs, allowing for distinguishing the samples from the healthy controls and the patients. Faustino et al., 2019 [50] Hyperbolic converging microchannels Human RBCs with magnetic NPs Extensional flow Deformation Index (DI)=X−YX+Y This microfluidic tool is capable of evaluating with high accuracy the impact of multifunctional nanoparticles designed for theranostic applications in contact with RBCs, using the proved extensional flow approach to measure with high accuracy the RBC’s DIs. Rodrigues et al., 2016 [73] Cross-flow microfluidic device with pillars Human RBCs (healthy) Cross-flow Deformation Index (DI)=X−YX+Y The proposed microfluidic device has the potential to perform in one single step a partial passive separation of RBCs based on their deformability by measuring the optical absorption of the collected samples. Faustino et al., 2018 [23] Hyperbolic converging microchannels Human RBCs (healthy and and artificially impaired) Shear and extensional flow Deformation Index (DI)=X−YX+Y This work is a valuable contribution to help establishing the development of new malaria diagnostic systems towards point-of-care devices. Vilas Boas et al., 2018 [74] Fire-shaped cylindrical glass micronozzles Human RBCs (healthy and and chemically treated) Extensional flow Deformation Index (DI)=X−YX+Y The use of these types of micronozzles, whose fabrication is simple, fast, and uses low-cost equipment, to assess the deformability (DI) of microentities, have great potential to detect small changes of blood cell mechanical properties. Rubio et al., 2019 [75] Polydimethylsiloxane (PDMS) rectangular abrupt contractions Human RBCs (healthy and chemically treated) Shear flow Deformation Index frequency of 10 kHz The RBC with higher deformability is more stretched along the flow direction (a), resulting in larger gaps between the RBC membrane and channel walls than the less deformable RBC (b). RBC with higher deformability blocks less current than RBC with lower deformability. Zeng et al., 2013 [78] 3. Blood Analogues—Particulate Approaches Human blood is a multiphase complex fluid that consists of a concentrated suspension of formed cellular elements (RBCs, WBCs, and platelets) in plasma [79]. However, the manipulation of real whole blood in vitro is difficult, not only because of ethical, economical, and safety problems but also because the rheological properties of blood vary with temperature, and it is difficult to control [80,81]. For these reasons, the development of reliable blood analogues to represent and reproduce the properties of human blood, is of great importance. In the literature, there are several proposed blood analogue fluids; however, they are mostly Newtonian fluids using mixtures of water/glycerol [82] and water/dimethylsulfoxide(DMSO) [83], or non-Newtonian analogue fluids based on aqueous solutions of xanthan gum (XG) and polyacrylamide (PAA) [84], in which the addition of glycerin is used to obtain the blood rheology at different hematocrit levels [84,85]. Early studies using particulate blood analogues were developed by Fukada et al., 1989 [86], who studied the rheological properties of polystyrene microsphere suspensions with Newtonian behavior and, by adding dextran and calcium chloride into the suspensions, a non-Newtonian behavior was obtained similar to that observed for human blood. Another early work was performed by Liepsch et al., 1991 [87], in which four non-Newtonian fluids were studied in order to determine how closely they simulate the flow behavior of human blood. The viscous and viscoelastic properties of these fluids were compared with human blood samples in steady and transient Couette flow and in an oscillatory tube flow. In the end, they verified that all fluids closely mimics the flow behavior of blood. Lerche et al., 1993 [88] studied different PAA solutions with different molecular weights and also with different concentrations, and they observed that all solutions are non-Newtonian and exhibit shear-thinning behavior. They stated that PAA solutions of appropriate concentration and molecular weight should be used to mimic the non-Newtonian steady shear viscosity of normal blood. As a continuation of the previous work, Vlastos et al., 1997 [89] compared the rheology of PAA and XG solutions at different concentrations for the preparation of blood analogue solutions and performed a combination of steady and oscillatory shear tests and found that the PAA (AP 273E) solution displayed a viscoelastic behavior close to that of blood at a concentration of 125 ppm and the XG at 500 ppm, at low shear regions, At the transition and higher shear regions, all model fluids studied at the above concentrations presented higher viscous and elastic components than blood. Sousa et al., 2011 [84] compared the flow of a Newtonian fluid and two well-established non-Newtonian blood analog polymer solutions of PAA and XG. They observed that despite their similar shear rheology, the flow patterns of the two blood analog solutions are considerably different and verified that the polyacrylamide solution exhibited a much stronger elastic character, demonstrating that elastic properties of the fluid have a major impact on the flow characteristics, so they need to be considered in the development of reliable blood analogues. Campo-Deaño et al., 2013 [81] developed four different polymer solutions (PAA+hyaluronic acid (HA)+DMSO; XG+DMSO; PAA+HA+sucrose; XG+sucrose) with different refractive indices (1.39 and 1.41) as viscoelastic blood analogues and they observed that the rheological behavior of the analogues obtained from steady shear and passive microrheology experiments is in good agreement with the rheological properties of whole human blood. Walker et al., 2014 [90] investigated the flow of a non-Newtonian blood analog of an aqueous solution of XG, on flow separation in both steady and pulsatile flow, and verified that the XG solution enhances the flow stabilization, which in turn emphasizes the importance of non-Newtonian blood characteristics on the resulting flow patterns in the presence of stenosis. Calejo et al., 2016 [91] and Pinho et al., 2017 [92] performed a study in which particulate Newtonian and non-Newtonian blood analogues were successfully developed, able to form the cell-free layer (CFL) downstream of a microfluidic hyperbolic contraction and to mimic the viscosity behavior of RBCs. Both solutions were composed of dextran 40 with rigid spheres particles of PMMA, and one of them exhibited a viscoelastic behavior due to the addition of XG. Nevertheless, the use of rigid particles limits the physiological realism of these studies. To overcome this limitation, over the years, several researchers have investigated other alternatives such as, polydimethylsiloxane (PDMS) microparticles [93,94,95] and hydrogel microparticles [96]. An example of the suitability of PDMS microparticle was presented by Pinho et al., 2019 [95]. They developed flexible PDMS microparticles to mimic RBCs in blood particulate analogue fluids and these showed a great potential to mimic the structural and rheological properties of RBCs suspensions and consequently to develop blood analogue fluids similar to real blood. The authors visualized the flow through a hyperbolic-shaped contraction and observed that all PDMS microparticles present some ability to elongate when passing through the smallest dimension of the microchannel. Figure 4 shows the deformation behavior of PDMS particles in comparison to RBCs and rigid particles of PMMA. They also verified that the final working fluid, formed of transparent PDMS microparticles, can reproduce the viscosity curve of human RBCs suspensions, showing an intermediate shear-thinning degree between healthy and pathological RBCs. The comparison between the viscosity of the working fluid and human RBCs suspensions is presented in Figure 5. Regarding the hydrogel microparticles, Chen et al., 2012 [97] synthetized deformable microgel particles loaded with bovine hemoglobin (Hb) mimicking the RBCs’ shape and size by using the PRINT (particle replication in nonwetting templates) technique. These particles demonstrated excellent deformability to pass through restricted pores half as wide as the diameter of the particles, and showed similar viscosity to that of mouse blood. In addition to the previous studies, another innovative blood analogue containing giant unilamellar vesicles (GUVs) with dimensions and mechanical properties similar to real RBCs was proposed by Carvalho et al., 2018 [98]. However, this method still needs improvements related to both visualization and the number of vesicles produced. Regardless the fact that all of these different blood analogues, summarized in Table 2, were able to reproduce the rheological properties of blood, only few are focused on the ability to reproduce the hemodynamic phenomena occurring in the blood flow at microcirculation scale under healthy or pathological blood conditions. It is important to achieve a high comprehension of healthy and pathological blood rheology, in particular the influence of RBCs lower deformability in the blood viscosity. In addition, the development of blood analogue fluids capable of mimic the RBCs behavior and the blood microcirculation phenomena at in vitro conditions is crucial. These analogue fluids are extremely important for experimental work since they minimize the use of real blood and the ethical issues. Lima and his colleagues have proposed a blood analogue fluid composed of Brij L4 [99] surfactant micelles suspended in pure water. This analogue is extremely easy to be produced and is able to investigate different kinds of microscale blood flow phenomena in simple and complex geometries. In addition, by using this analogue it is possible to track the flexible micelles avoiding sedimentation, aggregation, clogging and blockage difficulties that researchers have been pointed out by using rigid microparticles. In Table 2, it is clear that the analogue fluids do not present all the rheological and mechanical properties of the real whole blood at both micro and macro scale level. However, considering the desired application, most of the developed fluids have achieved their main purpose, for example in the case of the particulate ones, the flexible microparticles with diameters similar to RBCs, are able to mimic their deformability behavior when passing through narrow microfluidics contractions, at both pathological and healthy conditions. 4. Future Perspectives The main idea of personalized medicine is the concept of a patient-centered care and in this review, we have shown and discussed several tools that can couple with several detection methods and applied to specific patient needs in order to individually assess each problem. Thus, even for something more personalized or for a more general screening tools, microfluidic technology progress has promoted the ability to not only precisely control and manipulate fluids but it also has allowed medical researchers to develop clinical platforms for rapid sample analysis. The unique features of microfluidics are valuable for the progress of individualized medicine plans such as new treatment protocols and diagnosis approaches. Recently, individualized medicine research has been explored for applications such as point-of-care testing and individualized drug therapy. By applying microfluidic technologies, it is expected the improvement of the effectiveness in detecting biomolecules and monitoring individualized diagnosis and therapy studies in vitro and in vivo. The visualization and measurements of blood cells, flowing in microfluidic devices have been proven to be important in providing not only essential information about hydrodynamic characteristics of the blood, but also vital information to diagnose early symptoms of diseases during clinical investigations. For instance, point-of-care devices combined with flow visualization techniques, can be used to assess the cardiac risk profile of a specific patient and help the medical staff to decide the appropriate treatment and consequently to increase the chances of survival of this patient. Moreover, the new generation of blood analogue fluids, with the ability of reproducing healthy or pathological conditions, have been demonstrated to be a promising approach to improve the knowledge about several blood diseases. Ideally, particulate solutions having flexible particles that mimic key structural attributes of RBCs including size, shape, and mechanical properties would be an excellent candidate to reproduce multiphase effects of the blood flow in microcirculation. From a clinician’s perspective, it is still unclear about the translational part in particular with regard to personalize medicine. However, there are clear evidences that single cells analysis, in particular of RBCs provide a unique and specific information about the patient stratification, for example the overall outcome of clinical diabetes care and management. Acknowledgments Diana Pinho acknowledges the PhD scholarship SFRH/BD/89077/2012 attributed by FCT. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Author Contributions The authors contributed equally to the work. All authors have read and agreed to the published version of the manuscript. Funding This project has been funded by Portuguese national funds of FCT/MCTES (PIDDAC) through the base funding from the following research unit: UIDB/04077/2020, UIDB/00319/2020 and UIDB/00532/2020. The authors are also grateful for the partial funding of FCT through the projects NORTE-01-0145-FEDER-029394, NORTE-01-0145-FEDER-030171, funded by COMPETE2020, NORTE2020, PORTUGAL2020, and FEDER. Conflicts of Interest The authors declare no conflict of interest. Figure 1 Hemorheology combined with microfluidic technology can bring further advances in personalized medicine for new treatments and diagnosis. Figure 2 Microfluidic devices to assess of motions and deformations of red blood cells (RBCs) from healthy donors and pathological patients, e.g., chronic renal disease and diabetes mellitus [50]. ROI—Region of interest; PDMS—Polydimethylsiloxane; WBCs—White blood cells; RBCs—Red blood cells. Figure 3 Individual RBCs (a) velocity flowing through a sudden contraction microchannel for a flow rate of about 1 µL/min and (b) deformation index (DI). Figure 4 Behavior of healthy RBCs, flexible particles (PDMS) and rigid particles (PMMA) when flowing through a constriction in a microchannel. Adapted from [91,95]. Figure 5 Comparison between the viscosity of a blood solution and the analogue fluid with (a) PDMS particles and (b) xanthan gum and PMMA particles. Adapted from [79,95]. jpm-10-00249-t002_Table 2Table 2 Main fluids and particles used to mimic blood and RBCs behavior. Analogue Fluid Main Key Observations in Comparison to Whole Blood References Glycerol and water Newtonian, macro behavior, viscosity curve Lieber et al., 2009 [82] Water and DMSO Newtonian, macro behavior, viscosity curve Carvalho et al., 2020 [83,100], Souza et al., 2020 [101] Xanthan gum (XG) and PAA XG, PAA and glycerin Non-Newtonian, macro behavior, hematocrit level, shear-thinning Sousa et al., 2011 [84] Dextran 40 and CaCl2 Non-Newtonian, cell-free layer, micro behavior, hemodynamic phenomena, shear-thinning Fukada et al., 1989 [86] PAA Non-Newtonian, shear-thinning behavior Lerche et al., 1993 [88] PAA and XG Non-Newtonian, shear-thinning behavior, viscoelasticity Vlastos et al., 1997 [89] Sucrose, PAA and HA Non-Newtonian, macro behavior, shear-thinning behavior, viscoelasticity Campo-Deaño et al., 2013 [81] Sucrose and xanthan gum Non-Newtonian, macro behavior, shear-thinning behavior, viscoelasticity Campo-Deaño et al., 2013 [81] PMMA Newtonian, micro behavior, pathological RBCs deformability Calejo et al., 2016 [91] PMMA particles, xanthan gum, Dx 40 Non-Newtonian, micro behavior, shear-thinning behavior, viscoelasticity, pathological RBCs deformability, cell-free layer Pinho et al., 2017 [92] PDMS beads in Dx 40 Non-Newtonian, micro behavior, shear-tinning behavior, RBCs deformability Pinho et al., 2019 [95] Hydrogel Non-Newtonian, viscoelasticity Nguyen et al., 2004 [96] Microgel particles loaded with bovine Hb Newtonian, micro behavior, RBCs deformability Chen et al., 2012 [97] Giant unilamellar vesicles, water Newtonian, micro behavior, RBCs deformability Carvalho et al., 2018 [98] Brij L4 surfactant, water Non-Newtonian, micro behavior, two-phase, shear-thinning behavior, cell-free layer, RBCs deformability Lima et al., 2020 [99] ==== Refs References 1. Baskurt O.K. Hardeman M.R. Rampling M.W. Handbook of Hemorheology and Hemodynamics IOS Press Amsterdam, The Netherlands 2007 2. Baskurt O.K. Meiselman H.J. Blood Rheology and Hemodynamics Semin. Thromb. Hemost. 2003 29 435 450 10.1055/s-2003-44551 14631543 3. Bishop J.J. Popel A.S. Intaglietta M. Johnson P.C. Rheological effects of red blood cell aggregation in the venous network: A review of recent studies Biorheology 2001 38 263 274 11381180 4. De Cindio B. Gabriele D. Catapano G. Fata P. Hackel R. Bonofiglio R. The blood rheology in renal pathology Annali dell’Istituto Superiore di Sanita 2007 43 156 163 17634664 5. Tomaiuolo G. Biomechanical properties of red blood cells in health and disease towards microfluidics Biomicrofluidics 2014 8 051501 10.1063/1.4895755 25332724 6. Lee H. Na W. Lee S.B. Ahn C.W. Moon J.S. Won K.C. Shin S. Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes Front. Physiol. 2019 10 10.3389/fphys.2019.01062 7. Caprari P. Massimi S. Diana L. Sorrentino F. Maffei L. Materazzi S. Risoluti R. Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia Front. Mol. Biosci. 2019 6 142 10.3389/fmolb.2019.00142 31867341 8. Wiewiora M. Piecuch J. Gluck M. Slowinska-Lozynska L. Sosada K. The effects of weight loss surgery on blood rheology in severely obese patients Surg. Obes. Relat. Dis. 2015 11 1307 1314 10.1016/j.soard.2015.01.025 26048516 9. Senen K. Topal E. Kilinc E. ten Cate H. Tek I. Karakoc Y. Yetkin E. Plasma viscosity and mean platelet volume in patients undergoing coronary angiography Clin. Hemorheol. Microcirc. 2010 44 35 41 10.3233/CH-2010-1249 20134091 10. Cicco G. Pirrelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension Clin. Hemorheol. Microcirc. 1999 21 169 177 10711739 11. Bessonov N. Sequeira A. Simakov S. Vassilevskii Y. Volpert V. Methods of Blood Flow Modelling Math. Model. Nat. Phenom. 2016 11 1 25 10.1051/mmnp/201611101 12. Babu N. Singh M. Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes Clin. Hemorheol. Microcirc. 2004 31 273 280 15567897 13. Peng W.K. Chen L. Boehm B.O. Han J. Loh T.P. Molecular Phenotyping of Oxidative Stress in Diabetes Mellitus with Point-of-care NMR system bioRxiv 2019 565325 10.1038/s41514-020-00049-0 33083002 14. Loh T.P. Peng W.K. Chen L. Sethi S.K. Application of smoothed continuous labile haemoglobin A1c reference intervals for identification of potentially spurious HbA1c results J. Clin. Pathol. 2014 67 712 716 10.1136/jclinpath-2014-202346 24920681 15. Ritchie S.A. Connell J.M.C. The link between abdominal obesity, metabolic syndrome and cardiovascular disease Nutr. Metab. Cardiovasc. Dis. 2007 17 319 326 10.1016/j.numecd.2006.07.005 17110092 16. Shin S. Hou J.X. Suh J.S. Singh M. Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability Clin. Hemorheol. Microcirc. 2007 37 319 328 17942984 17. Yeom E. Lee S.J. Microfluidic-based speckle analysis for sensitive measurement of erythrocyte aggregation: A comparison of four methods for detection of elevated erythrocyte aggregation in diabetic rat blood Biomicrofluidics 2015 9 024110 10.1063/1.4917023 25945136 18. Zeng H. Zhao Y. Rheological analysis of non-Newtonian blood flow using a microfluidic device Sensors Actuators A Phys. 2011 166 207 213 10.1016/j.sna.2010.01.031 19. Brown C.D. Ghali H.S. Zhao Z. Thomas L.L. Friedman E.L.I.A. Association of reduced red blood cell deformability and diabetic nephropathy Kidney Int. 2005 67 295 300 10.1111/j.1523-1755.2005.00082.x 15610255 20. Dalili A. Samiei E. Hoorfar M. A review of sorting, separation and isolation of cells and microbeads for biomedical applications: Microfluidic approaches Analyst 2019 144 87 113 10.1039/C8AN01061G 21. Lenshof A. Ahmad-Tajudin A. Järås K. Swärd-Nilsson A.M. Aberg L. Marko-Varga G. Malm J. Lilja H. Laurell T. Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics Anal. Chem. 2009 81 6030 6037 10.1021/ac9013572 19594154 22. Mellors J.S. Jorabchi K. Smith L.M. Ramsey J.M. Integrated microfluidic device for automated single cell analysis using electrophoretic separation and electrospray ionization mass spectrometry Anal. Chem. 2010 82 967 973 10.1021/ac902218y 20058879 23. Faustino V. Catarino S.O. Pinho D. Lima R.A. Minas G. A Passive Microfluidic Device Based on Crossflow Filtration for Cell Separation Measurements: A Spectrophotometric Characterization Biosensors 2018 8 125 10.3390/bios8040125 30544881 24. Sajeesh P. Sen A.K. Particle separation and sorting in microfluidic devices: A review Microfluid. Nanofluidics 2014 17 1 52 10.1007/s10404-013-1291-9 25. Wu H. Zhu J. Huang Y. Wu D. Sun J. Microfluidic-Based Single-Cell Study: Current Status and Future Perspective Molecules 2018 23 2347 10.3390/molecules23092347 26. Pinho D. Yaginuma T. Lima R. A microfluidic device for partial cell separation and deformability assessment BioChip J. 2013 7 367 374 10.1007/s13206-013-7408-0 27. Rodrigues R.O. Pinho D. Faustino V. Lima R. A simple microfluidic device for the deformability assessment of blood cells in a continuous flow Biomed. Microdevices 2015 17 108 10.1007/s10544-015-0014-2 26482154 28. Siddhartha T. Kumar Y.V.B.V. Amit P. Suhas S.J. Amit A. Passive blood plasma separation at the microscale: A review of design principles and microdevices J. Micromechan. Microeng. 2015 25 083001 29. Yu Z.T.F. Yong K.M.A. Fu J. Microfluidic Blood Cell Preparation: Now and Beyond Small 2014 10 1687 1703 10.1002/smll.201302907 24515899 30. Chen X. Cui D.F. Liu C.C. Li H. Microfluidic chip for blood cell separation and collection based on crossflow filtration Sens. Actuators B Chem. 2008 130 216 221 10.1016/j.snb.2007.07.126 31. Fujiwara H. Ishikawa T. Lima R. Matsuki N. Imai Y. Kaji H. Nishizawa M. Yamaguchi T. Red blood cell motions in high-hematocrit blood flowing through a stenosed microchannel J. Biomech. 2009 42 838 843 10.1016/j.jbiomech.2009.01.026 19268948 32. Peng W.K. Paesani D. Omics Meeting Onics: Towards the Next Generation of Spectroscopic-Based Technologies in Personalized Medicine J. Pers. Med. 2019 9 39 10.3390/jpm9030039 31374867 33. Mohammadi Aria M. Erten A. Yalcin O. Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing Front. Bioeng. Biotechnol. 2019 7 395 10.3389/fbioe.2019.00395 31921804 34. Sackmann E.K. Fulton A.L. Beebe D.J. The present and future role of microfluidics in biomedical research Nature 2014 507 181 189 10.1038/nature13118 24622198 35. Catarino S.O. Rodrigues R.O. Pinho D. Miranda J.M. Minas G. Lima R. Blood Cells Separation and Sorting Techniques of Passive Microfluidic Devices: From Fabrication to Applications Micromachines 2019 10 593 10.3390/mi10090593 31510012 36. Convery N. Gadegaard N. 30 years of microfluidics Micro Nano Eng. 2019 2 76 91 10.1016/j.mne.2019.01.003 37. Gale B.K. Jafek A.R. Lambert C.J. Goenner B.L. Moghimifam H. Nze U.C. Kamarapu S.K. A review of current methods in microfluidic device fabrication and future commercialization prospects Inventions 2018 3 60 10.3390/inventions3030060 38. Gorgannezhad L. Stratton H. Nguyen N.-T. Microfluidic-Based Nucleic Acid Amplification Systems in Microbiology Micromachines 2019 10 408 10.3390/mi10060408 39. Li Z. Ju R. Sekine S. Zhang D. Zhuang S. Yamaguchi Y. All-in-one microfluidic device for on-site diagnosis of pathogens based on an integrated continuous flow PCR and electrophoresis biochip Lab Chip 2019 19 2663 2668 10.1039/C9LC00305C 31273367 40. Shrirao A.B. Fritz Z. Novik E.M. Yarmush G.M. Schloss R.S. Zahn J.D. Yarmush M.L. Microfluidic flow cytometry: The role of microfabrication methodologies, performance and functional specification Technology 2018 6 1 23 10.1142/S2339547818300019 29682599 41. Ribeiro-Samy S. Oliveira M.I. Pereira-Veiga T. Muinelo-Romay L. Carvalho S. Gaspar J. Freitas P.P. López-López R. Costa C. Diéguez L. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients Sci. Rep. 2019 9 8032 10.1038/s41598-019-44401-1 31142796 42. Wang X. Yi L. Mukhitov N. Schrell A.M. Dhumpa R. Roper M.G. Microfluidics-to-mass spectrometry: A review of coupling methods and applications J. Chromatogr. A 2015 1382 98 116 10.1016/j.chroma.2014.10.039 25458901 43. Dhagat V. Microfluidics and Sensors for DNA Analysis Int. J. Eng. Res. Sci. 2017 3 83 91 44. Zhang Y. Xiao R.-R. Yin T. Zou W. Tang Y. Ding J. Yang J. Generation of Gradients on a Microfluidic Device: Toward a High-Throughput Investigation of Spermatozoa Chemotaxis PLoS ONE 2015 10 e0142555 10.1371/journal.pone.0142555 26555941 45. Yan S. Zhang J. Yuan D. Li W. Hybrid microfluidics combined with active and passive approaches for continuous cell separation Electrophoresis 2016 38 238 249 10.1002/elps.201600386 27718260 46. Jackson E.L. Lu H. Advances in microfluidic cell separation and manipulation Curr. Opin. Chem. Eng. 2013 2 398 404 10.1016/j.coche.2013.10.001 24701393 47. Tu C. Huang B. Zhou J. Liang Y. Tian J. Ji L. Liang X. Ye X. A Microfluidic Chip for Cell Patterning Utilizing Paired Microwells and Protein Patterns Micromachines 2016 8 1 10.3390/mi8010001 48. Shinde P. Mohan L. Kumar A. Dey K. Maddi A. Patananan N.A. Tseng F.-G. Chang H.-Y. Nagai M. Santra S.T. Current Trends of Microfluidic Single-Cell Technologies Int. J. Mol. Sci. 2018 19 3143 10.3390/ijms19103143 49. Toepfner N. Herold C. Otto O. Rosendahl P. Jacobi A. Kräter M. Stächele J. Menschner L. Herbig M. Ciuffreda L. Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood eLife 2018 7 e29213 10.7554/eLife.29213 29331015 50. Faustino V. Rodrigues R.O. Pinho D. Costa E. Santos-Silva A. Miranda V. Amaral J.S. Lima R. A Microfluidic Deformability Assessment of Pathological Red Blood Cells Flowing in a Hyperbolic Converging Microchannel Micromachines 2019 10 645 10.3390/mi10100645 51. Bento D. Rodrigues R.O. Faustino V. Pinho D. Fernandes C.S. Pereira A.I. Garcia V. Miranda J.M. Lima R. Deformation of red blood cells, air bubbles, and droplets in microfluidic devices: Flow visualizations and measurements Micromachines 2018 9 151 10.3390/mi9040151 52. Rodrigues R.O. Sousa P. Gaspar J. Bañobre-López M. Lima R. Minas G. Organ-on-a-chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine Small 2020 2003517 1 19 10.1002/smll.202003517 53. Peng W.K. Kong T.F. Ng C.S. Chen L. Huang Y. Bhagat A.A.S. Nguyen N.-T. Preiser P.R. Han J. Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis Nat. Med. 2014 20 1069 1073 10.1038/nm.3622 25173428 54. Dupré A. Lei K.-M. Mak P.-I. Martins R.P. Peng W.K. Micro- and nanofabrication NMR technologies for point-of-care medical applications—A review Microelectron. Eng. 2019 209 66 74 10.1016/j.mee.2019.02.005 55. Peng W.K. Chen L. Han J. Development of miniaturized, portable magnetic resonance relaxometry system for point-of-care medical diagnosis Rev. Sci. Instrum. 2012 83 095115 10.1063/1.4754296 23020427 56. Toh R.J. Peng W.K. Han J. Pumera M. Direct In Vivo Electrochemical Detection of Haemoglobin in Red Blood Cells Sci. Rep. 2014 4 6209 10.1038/srep06209 25163492 57. Toh R.J. Peng W.K. Han J. Pumera M. Haemoglobin electrochemical detection on various reduced graphene surfaces: Well-defined glassy carbon electrode outperforms the graphenoids RSC Adv. 2014 4 8050 8054 10.1039/c3ra45417g 58. Tzeng B.-B. Sun Y.-S. Design and Fabrication of a Microfluidic Viscometer Based on Electrofluidic Circuits Micromachines 2018 9 375 10.3390/mi9080375 59. André E. Pannacci N. Dalmazzone C. Colin A. A new way to measure viscosity in droplet-based microfluidics for high throughput analysis Soft Matter 2019 15 504 514 10.1039/C8SM02372G 30607416 60. Magnusson E.B. Halldorsson S. Fleming R.M.T. Leosson K. Real-time optical pH measurement in a standard microfluidic cell culture system Biomed. Opt. Express 2013 4 1749 1758 10.1364/BOE.4.001749 24049695 61. Yamada A. Suzuki M. A Microfluidic pH Measurement Device with a Flowing Liquid Junction Sensors 2017 17 1563 10.3390/s17071563 62. Nguyen N.-T. Hejazian M. Ooi H.C. Kashaninejad N. Recent Advances and Future Perspectives on Microfluidic Liquid Handling Micromachines 2017 8 186 10.3390/mi8060186 63. Tripathi S. Kumar Y.V. Agrawal A. Prabhakar A. Joshi S.S. Microdevice for plasma separation from whole human blood using bio-physical and geometrical effects Sci. Rep. 2016 6 26749 10.1038/srep26749 27279146 64. Zheng Y. Nguyen J. Wei Y. Sun Y. Recent advances in microfluidic techniques for single-cell biophysical characterization Lab Chip 2013 13 2464 2483 10.1039/c3lc50355k 23681312 65. Myers F.B. Lee L.P. Innovations in optical microfluidic technologies for point-of-care diagnostics Lab Chip 2008 8 2015 2031 10.1039/b812343h 19023464 66. Chen H. Zhang Z. Liu H. Zhang Z. Lin C. Wang B. Hybrid magnetic and deformability based isolation of circulating tumor cells using microfluidics AIP Adv. 2019 9 025023 10.1063/1.5081849 67. Yasukawa T. Nagamine K. Horiguchi Y. Shiku H. Koide M. Itayama T. Shiraishi F. Matsue T. Electrophoretic Cell Manipulation and Electrochemical Gene-Function Analysis Based on a Yeast Two-Hybrid System in a Microfluidic Device Anal. Chem. 2008 80 3722 3727 10.1021/ac800143t 18363337 68. Agrawal R. Smart T. Nobre-Cardoso J. Richards C. Bhatnagar R. Tufail A. Shima D. Jones P.H. Pavesio C. Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique Sci. Rep. 2016 6 15873 10.1038/srep15873 26976672 69. Zeng N.F. Mancuso J.E. Zivkovic A.M. Smilowitz J.T. Ristenpart W.D. Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction PLoS ONE 2016 11 e0156070 10.1371/journal.pone.0156070 27258098 70. Barber B.E. Russell B. Grigg M.J. Zhang R. William T. Amir A. Lau Y.L. Chatfield M.D. Dondorp A.M. Anstey N.M. Reduced red blood cell deformability in Plasmodium knowlesi malaria Blood Adv. 2018 2 433 443 10.1182/bloodadvances.2017013730 29487058 71. Rey J. Buffet P.A. Ciceron L. Milon G. Mercereau-Puijalon O. Safeukui I. Reduced erythrocyte deformability associated with hypoargininemia during Plasmodiumfalciparum malaria Sci. Rep. 2014 4 3767 10.1038/srep03767 24441939 72. Kong T.F. Ye W. Peng W.K. Hou H.W. Preiser P.R. Nguyen N.-T. Han J. Enhancing malaria diagnosis through microfluidic cell enrichment and magnetic resonance relaxometry detection Sci. Rep. 2015 5 11425 10.1038/srep11425 26081638 73. Rodrigues R.O. Bañobre-López M. Gallo J. Tavares P.B. Silva A.M.T. Lima R. Gomes H.T. Haemocompatibility of iron oxide nanoparticles synthesized for theranostic applications: A high-sensitivity microfluidic tool J. Nanoparticle Res. 2016 18 194 10.1007/s11051-016-3498-7 74. Boas L.V. Faustino V. Lima R. Miranda J.M. Minas G. Fernandes C.S.V. Catarino S.O. Assessment of the Deformability and Velocity of Healthy and Artificially Impaired Red Blood Cells in Narrow Polydimethylsiloxane (PDMS) Microchannels Micromachines 2018 9 384 10.3390/mi9080384 30424317 75. Rubio A. Faustino V. Cabezas M.G. Lima R. Vega E.J. Fire-shaped cylindrical glass micronozzles to measure cell deformability J. Micromechan. Microeng. 2019 29 105001 10.1088/1361-6439/ab3183 76. Cruz A. Peng W.K. Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology J. Pers. Med. 2019 9 44 10.3390/jpm9030044 77. Iliescu F.S. Poenar D.P. Yu F. Ni M. Chan K.H. Cima I. Taylor H.K. Cima I. Iliescu C. Recent advances in microfluidic methods in cancer liquid biopsy Biomicrofluidics 2019 13 041503 10.1063/1.5087690 31431816 78. Zheng Y. Nguyen J. Wang C. Sun Y. Electrical measurement of red blood cell deformability on a microfluidic device Lab Chip 2013 13 3275 3283 10.1039/c3lc50427a 23798004 79. 7—Microfluidic Devices Based on Biomechanics Integrated Nano-Biomechanics Yamaguchi T. Ishikawa T. Imai Y. Elsevier Boston, MA, USA 2018 217 263 10.1016/B978-0-323-38944-0.00007-3 80. Carvalho V. Maia I. Souza A. Ribeiro J. Costa P. Puga H. Teixeira S.F.C.F. Lima R.A. In vitro stenotic arteries to perform blood analogues flow visualizations and measurements: A Review Open Biomed. Eng. J. 2020 in press 81. Campo-Deaño L. Dullens R.P.A. Aarts D.G.A.L. Pinho F.T. Oliveira M.S.N. Viscoelasticity of blood and viscoelastic blood analogues for use in polydymethylsiloxane in vitro models of the circulatory system Biomicrofluidics 2013 7 034102 10.1063/1.4804649 82. Lieber B.B. Sadasivan C. Hao Q. Seong J. Cesar L. The mixability of angiographic contrast with arterial blood Med. Phys. 2009 36 5064 5078 10.1118/1.3243079 19994517 83. Carvalho V. Rodrigues N. Ribeiro R. Costa P.F. Lima R.A. Teixeira S.F.C.F. 3D Printed Biomodels for Flow Visualization in Stenotic Vessels: An Experimental and Numerical Study Micromachines 2020 11 549 10.3390/mi11060549 32485816 84. Sousa P.C. Pinho F.T. Oliveira M.S.N. Alves M.A. Extensional flow of blood analog solutions in microfluidic devices Biomicrofluidics 2011 5 014108 10.1063/1.3567888 21483662 85. Broek C.N. Medium with Blood-Analog Mechanical Properties for Cardiovascular Tissue Culturing IOS Press Eindhoven, The Netherlands 2008 651 661 86. Fukada E. Seaman G.V.F. Liepsch D. Lee M. Friis-Baastad L. Blood modeling using polystyrene microspheres Biorheology 1989 26 401 413 10.3233/BIR-1989-26222 2481519 87. Liepsch D. Thurston G. Lee M. Studies of fluids simulating blood-like rheological properties and applications in models of arterial branches Biorheology 1991 28 39 52 10.3233/BIR-1991-281-205 2049531 88. Lerche D. Vlastos G. Koch B. Pohl M. Affeld K. Viscoelastic behaviour of human blood and polyacrylamide model fluids for heart valve testing J. Phys. 1993 3 1283 1289 10.1051/jp3:1993198 89. Vlastos G. Lerche D. Koch B. Samba O. Pohl M. The effect of parallel combined steady and oscillatory shear flows on blood and polymer solutions Rheol. Acta 1997 36 160 172 10.1007/BF00366822 90. Walker A.M. Johnston C.R. Rival D.E. On the Characterization of a Non-Newtonian Blood Analog and Its Response to Pulsatile Flow Downstream of a Simplified Stenosis Ann. Biomed. Eng. 2014 42 97 109 10.1007/s10439-013-0893-4 23975383 91. Calejo J. Pinho D. Galindo-Rosales F. Lima R. Campo-Deaño L. Particulate Blood Analogues Reproducing the Erythrocytes Cell-Free Layer in a Microfluidic Device Containing a Hyperbolic Contraction Micromachines 2016 7 4 10.3390/mi7010004 92. Pinho D. Muñoz-Sánchez B.N. Vega E.J. Lima R. Pinho F.T. Rheological behaviour of dextran suspensions of PDMS microbeads flowing through a hyperbolic microchannel Proceedings of the 7th Portuguese Congress on Biomecahnics Guimarães, Portugal 10–11 February 2017 93. Muñoz-Sánchez B.N. Silva S.F. Pinho D. Vega E.J. Lima R. Generation of micro-sized PDMS particles by a flow focusing technique for biomicrofluidics applications Biomicrofluidics 2016 10 014122 10.1063/1.4943007 27042245 94. Choi J. Hyun J.-C. Yang S. On-chip Extraction of Intracellular Molecules in White Blood Cells from Whole Blood Sci. Rep. 2015 5 15167 10.1038/srep15167 26464211 95. Pinho D. Muñoz-Sánchez B.N. Anes C.F. Vega E.J. Lima R. Flexible PDMS microparticles to mimic RBCs in blood particulate analogue fluids Mech. Res. Commun. 2019 100 103399 10.1016/j.mechrescom.2019.103399 96. Nguyen T.T. Mongrain R. Prakash S. Tardif J.C. Development of a Blood Analog for the Hernodynamic Efficiency Evaluation of Cardiovascular Devices Proceedings of the Canadian Design Engineering Network Conference Montreal, QC, Canada 29–30 July 2004 97. Chen K. Merkel T.J. Pandya A. Napier M.E. Luft J.C. Daniel W. Sheiko S. DeSimone J.M. Low Modulus Biomimetic Microgel Particles with High Loading of Hemoglobin Biomacromolecules 2012 13 2748 2759 10.1021/bm3007242 22852860 98. Carvalho D.A.M. Rodrigues A.R.O. Faustino V. Pinho D. Castanheira E.M.S. Lima R. Microfluidic Deformability Study of an Innovative Blood Analogue Fluid Based on Giant Unilamellar Vesicles J. Funct. Biomater. 2018 9 70 10.3390/jfb9040070 30518160 99. Lima R. Vega E.J. Moita A.S. Miranda J.M. Pinho D. Moreira A.L.N. Fast, flexible and low-cost multiphase blood analogue for biomedical and energy applications Exp. Fluids 2020 61 231 10.1007/s00348-020-03066-7 100. Carvalho V. Rodrigues N. Ribeiro R. Costa P.F. Teixeira J.C.F. Lima R.A. Teixeira S.F.C.F. Hemodynamic study in 3D printed stenotic coronary artery models: Experimental validation and transient simulation Comput. Methods Biomech. Biomed. Engin. 2020 1 14 10.1080/10255842.2020.1842377 101. Souza A. Souza M.S. Pinho D. Agujetas R. Ferrera C. Lima R. Puga H. Ribeiro J. 3D manufacturing of intracranial aneurysm biomodels for flow visualizations: Low cost fabrication processes Mech. Res. Commun. 2020 107 103535 10.1016/j.mechrescom.2020.103535